SourcingAI
Try for free
Powered by Made-in-China.com
GMP Ampicillin Sodium for Injection 0.25g
US$0.05
10,000-199,999 vial
US$0.10
200,000+ vial

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Internal Use

Model NO.

0.25g; 0.5g; 1.0g

Suitable for

Elderly, Children, Adult

State

Powder

Shape

Powder

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H37021936

Transport Package

1vial/Box; 10vials/Box; 50vials/Box

Specification

50*26*32 CM

Trademark

Reyoung

Origin

China

Production Capacity

2, 000, 000, 000 Per Year

Key features

Broad-Spectrum Antibiotic: Treats respiratory, GI, urinary tract, skin, meningitis, sepsis, and endocarditis infections.
Global GMP Certified: Passed Chinese GMP, PIC/S, and audits in Ethiopia, Uganda, Kenya, Pakistan, and more.
Established Manufacturer: Reyoung Pharma established in 1966, with 3 factory sites and 30+ workshops.
International Reach: Products exported to over 70 countries and NGOs since 1997.
Multiple Administration Routes: Can be administered via intramuscular injection or intravenous infusion.
Suitable for All Ages: Approved for use in elderly, children, and adult patients.
OEM/ODM Services: Offers OEM and ODM services for customized pharmaceutical needs.
High Production Capacity: 1 million square meter plant area with 4950 employees and 370 R&D engineers.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.
Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.
CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.
R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.
Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.
Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:What infections does Ampicillin Sodium treat?
A:
It treats infections caused by sensitive bacteria, including upper and lower respiratory tract, gastrointestinal, urinary tract, skin and soft tissue infections, meningitis, sepsis, and endocarditis.
Q:How is the medication administered?
A:
Ampicillin sodium is a powder for injection that can be administered intramuscularly or intravenously.
Q:Is this product suitable for children?
A:
Yes, the product is suitable for elderly, children, and adult patients.
Q:What certifications does Reyoung Pharma hold?
A:
Reyoung has passed Chinese GMP and international audits including PIC/S GMP, TFDA, NAFDAC, and certifications in Ethiopia, Uganda, Kenya, Ghana, and Pakistan.
Q:Can I order OEM or ODM services?
A:
Yes, Reyoung Pharma offers both OEM and ODM services for pharmaceutical products.

Send Inquiry

*To:Reyoung Pharmaceutical Co., Ltd.Reyoung Pharmaceutical Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like